Phase II Study of Doxil and Carboplatin, Plus Herceptin in HER2+ Patients, in Metastatic Breast Cancer
Interventional
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Primary Objective
To determine the ORR associated with Doxil in combination with carboplatin in HER2- (negative) MBC (and with Herceptin in HER2+ MBC)
No
Rufus P Collea, MD
Principal Investigator
US Oncology Research
United States: Food and Drug Administration
04111
NCT00303108
December 2005
March 2010
Name | Location |
---|---|
Texas Oncology, P.A. | Dallas, Texas 75246 |
Virginia Oncology Associates | Newport News, Virginia 23606 |
Comprehensive Cancer Centers of Nevada | Las Vegas, Nevada 89109 |
Ocala Oncology Center | Ocala, Florida 34474 |
Missouri Cancer Associates | Columbia, Missouri 65201 |
New Mexico Cancer Care Associates | Santa Fe, New Mexico 87505-7670 |
Tyler Cancer Center | Tyler, Texas 75702 |
Texas Oncology, PA | Dallas, Texas 75246-2006 |
Northwest Cancer Specialists-Vancouver | Vancouver, Washington 98684 |
Medical Oncology Associates | Kingston, Pennsylvania 18704 |
Florida Cancer Institute | New Port Richey, Florida 34652 |
Central Indiana Cancer Centers | Indianapolis, Indiana 46227 |
Texas Cancer Center at Medical City | Dallas, Texas 75230 |
West Texas Cancer Center | Odessa, Texas 79761 |
Hematology Oncology Associates | Phoenix, Arizona 85012 |
Greater Dayton Cancer Center | Kettering, Ohio 45409 |
Birmingham Hematology and Oncology | Birmingham, Alabama 35235 |
Texas Cancer Center | Abilene, Texas 79606 |
Mamie McFaddin Ward Cancer Center | Beaumont, Texas 77702 |
Lake Vista Cancer Center | Lewisville, Texas 75067 |
Longview Cancer Center | Longview, Texas 75601 |
Texas Cancer Center of Mesquite | Mesquite, Texas 75150 |
Cancer Care Northwest-North | Spokane, Washington 99218 |
Raleigh Hematology Oncology Associates | Cary, North Carolina 27511 |
Minnesota Oncology Hematology, PA | Minneapolis, Minnesota 55404 |
New York Oncology Hematology, PC | Albany, New York 12208 |
Paris Regional Cancer Center | Paris, Texas 75460 |
Hematology Oncology Associates of IL | Chicago, Illinois 60611 |
Maryland Oncology Hematology, PA | Columbia, Maryland 21044 |
Rocky Mountain Cancer Center-Rose | Denver, Colorado 80220 |
El Paso Cancer Treatment Ctr | El Paso, Texas 79915 |
South Texas Cancer Center-McAllen | McAllen, Texas 78503 |
Texas Cancer Center-Sherman | Sherman, Texas 75090 |
Texas Oncology Cancer Center-Sugar Land | Sugar Land, Texas 77479 |
Puget Sound Cancer Center-Seattle | Seattle, Washington 98133 |
Yakima Valley Mem Hosp/North Star Lodge | Yakima, Washington 98902 |
Fairfax Northern VA Hem-Onc PC | Fairfax, Virginia 22031 |
Puget Sound Cancer Center-Edmonds | Edmonds, Washington 98026 |
Kansas City Cancer Centers-Southwest | Overland Park, Kansas 66210 |
Texas Cancer Center-Denton | Denton, Texas 76210 |
Northern AZ Hematology & Oncology Associates-Sedona | Sedona, Arizona 86336 |
Cancer Care & Hematology Specialists of Chicagoland, PC | Niles, Illinois 60714 |
Flavio Kruter, MD, PA | Westminster, Maryland 21157 |
Ruth Oratz MD | New York, New York 10016 |
Willamette Vallejy Cancer Center | Eugene, Oregon 97401 |
Texas Cancer Center - Abilene (South) | Abilene, Texas 79606 |
Texas Oncology, P.A.-Amarillo | Amarillo, Texas 79106 |
Texas Oncology, PA-Bedford | Bedford, Texas 76022 |
The TexasCancer Center | Dallas, Texas 75237 |
Alison Cancer Center | Midland, Texas 79701 |
HOAST-Medical Dr. | San Antonio, Texas 78229 |
Texas Oncology Cancer Care and Research Center-Waco | Waco, Texas 76712 |
Onc and Hem Associates of SW VA, Inc | Salem, Virginia 24153 |